It is recommended that additional studies be conducted to observe the relationship between aberrant CD7 expression, cytogenetics, and other molecular abnormalities in patients with AML and to determine whether CD7 antigen expression influences survival, recurrence, and treatment response. Here, CD7 is linked to acute myeloid leukemia.